Return-path: <sales_marketing+bncBDLNJ55JYIPBB7OVUGXQKGQE6OGYFRI@ferozsons-labs.com>
Envelope-to: umar.abbas@bfbio.com
Delivery-date: Thu, 03 Sep 2015 08:45:07 -0700
Received: from mail-pa0-f72.google.com ([209.85.220.72]:33898)
	by biz157.inmotionhosting.com with esmtps (TLSv1.2:AES128-GCM-SHA256:128)
	(Exim 4.85)
	(envelope-from <sales_marketing+bncBDLNJ55JYIPBB7OVUGXQKGQE6OGYFRI@ferozsons-labs.com>)
	id 1ZXWhC-0002lq-To
	for umar.abbas@bfbio.com; Thu, 03 Sep 2015 08:45:06 -0700
Received: by pav10 with SMTP id 10sf30650751pav.1
        for <umar.abbas@bfbio.com>; Thu, 03 Sep 2015 08:45:02 -0700 (PDT)
X-Google-DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed;
        d=1e100.net; s=20130820;
        h=x-gm-message-state:date:from:to:subject:reply-to:sender:feedback-id
         :list-unsubscribe:mime-version:content-type:message-id
         :x-original-sender:x-original-authentication-results:precedence
         :mailing-list:list-id:x-spam-checked-in-group:list-post:list-help
         :list-archive;
        bh=o3tD8LhjuarVMbLh+121lX2NGeSxqppsqAYtja8Y3ig=;
        b=C5iIBqfESX2Mf0ZmQ0zTYMHG1REQfeoC96ruLzJD5210JXcGYGerfJ0ie6eSXnYHbE
         19hWBobMDu4tAFERwUHloNdZpoZFlE8TFSjJJ76zFP5YbkN9IoQznu4t9DFT9j8Rt6KB
         FOMIkXPTX+J22Yokp07aflrIERtLPdvFG02/wyU3hqZfZ63zJSGx/1of6cZ1S2WrQLlR
         nOEYdBzeIDBO7+prEuRB0tPKB51jyzjOV1pmLYffryZLjTZnNoGxgUzxaCFW2ZroakqY
         P+r5ltQo4KrdZNzrFaM0iO8Rb01fSzaotTQ5aZjCs+eYWDK0ZI1qQOEZ5TmEpyKHaoow
         7t6g==
X-Gm-Message-State: ALoCoQlmKuY/MouolKQKn5PjbUNBzuhETGeDxxklRRZHMFt86yF5s2gQl/IQ+FoEaxx2RsrciTo4
X-Received: by 10.66.131.4 with SMTP id oi4mr29700401pab.16.1441295102233;
        Thu, 03 Sep 2015 08:45:02 -0700 (PDT)
X-BeenThere: sales_marketing@ferozsons-labs.com
Received: by 10.140.88.203 with SMTP id t69ls491864qgd.78.gmail; Thu, 03 Sep
 2015 08:45:01 -0700 (PDT)
X-Received: by 10.55.198.157 with SMTP id s29mr38555707qkl.36.1441295101050;
        Thu, 03 Sep 2015 08:45:01 -0700 (PDT)
Received: from mail196.magnet101.com (mail196.magnet101.com. [209.18.93.196])
        by mx.google.com with ESMTP id r143si30325327qha.31.2015.09.03.08.45.00
        for <sales_marketing@ferozsons-labs.com>;
        Thu, 03 Sep 2015 08:45:01 -0700 (PDT)
Received-SPF: pass (google.com: domain of bounce@mmsend24.com designates 209.18.93.196 as permitted sender) client-ip=209.18.93.196;
Received: from RMPMTA01 (172.17.196.1) by mail196.magnet101.com id ht1lfq15hf8v for <sales_marketing@ferozsons-labs.com>; Thu, 3 Sep 2015 11:44:54 -0400 (envelope-from <bounce@mmsend24.com>)
Date: Thu, 03 Sep 2015 11:44:53 -0400
From: "Life Science Training Institute" <training@lifesciencetraininginstitute.com>
To: <sales_marketing@ferozsons-labs.com>
Subject: Encore Presentation! FDA Guidance on Social Media: Questions Answered and Unanswered
Reply-To: training@lifesciencetraininginstitute.com
Sender: "Life Science Training Institute" <training@lifesciencetraininginstitute.mmsend.com>
X-TokenInfo-NoToken: 
Feedback-ID: 10289:10289_2258865:10289_29602822:realmagnet
x-jobid: 29602822
List-Unsubscribe: <mailto:googlegroups-manage+358213415174+unsubscribe@googlegroups.com>,
 <http://groups.google.com/a/ferozsons-labs.com/group/sales_marketing/subscribe>
X-Bps1: 27390996552
MIME-Version: 1.0
Content-Type: multipart/alternative; boundary="_NextPart_000_10960188_201593_114453747"
Message-ID: <0.0.0.249.1D0E65F7AA20277.53D57@mail196.magnet101.com>
X-Original-Sender: training@lifesciencetraininginstitute.com
X-Original-Authentication-Results: mx.google.com;       spf=pass (google.com:
 domain of bounce@mmsend24.com designates 209.18.93.196 as permitted sender)
 smtp.mailfrom=bounce@mmsend24.com;       dkim=pass header.i=@mmsend.com
Precedence: list
Mailing-list: list sales_marketing@ferozsons-labs.com; contact sales_marketing+owners@ferozsons-labs.com
List-ID: <sales_marketing.ferozsons-labs.com>
X-Spam-Checked-In-Group: sales_marketing@ferozsons-labs.com
X-Google-Group-Id: 358213415174
List-Post: <http://groups.google.com/a/ferozsons-labs.com/group/sales_marketing/post>,
 <mailto:sales_marketing@ferozsons-labs.com>
List-Help: <http://support.google.com/a/ferozsons-labs.com/bin/topic.py?topic=25838>,
 <mailto:sales_marketing+help@ferozsons-labs.com>
List-Archive: <http://groups.google.com/a/ferozsons-labs.com/group/sales_marketing/>
X-Spam-Status: No, score=-0.9
X-Spam-Score: -8
X-Spam-Bar: /
X-Ham-Report: Spam detection software, running on the system "biz157.inmotionhosting.com",
 has NOT identified this incoming email as spam.  The original
 message has been attached to this so you can view it or label
 similar future email.  If you have any questions, see
 root\@localhost for details.
 
 Content preview:  To see the web version of this message click here: http://contentsharing.net/actions/email_web_version.cfm?recipient_id=2295734738&message_id=10960188&user_id=VERTMARKET&jobid=29602822
    Hello Noor - In 2014, FDA provided guidance on the proper use of social media
    for makers of prescription products. As the new year unfolds, many questions
    remain about how to properly implement these guidelines. [...] 
 
 Content analysis details:   (-0.9 points, 5.0 required)
 
  pts rule name              description
 ---- ---------------------- --------------------------------------------------
  0.0 URIBL_BLOCKED          ADMINISTRATOR NOTICE: The query to URIBL was blocked.
                             See
                             http://wiki.apache.org/spamassassin/DnsBlocklists#dnsbl-block
                              for more information.
                             [URIs: ferozsons-labs.com]
 -0.7 RCVD_IN_DNSWL_LOW      RBL: Sender listed at http://www.dnswl.org/, low
                             trust
                             [209.85.220.72 listed in list.dnswl.org]
  0.1 URIBL_SBL_A            Contains URL's A record listed in the SBL blocklist
                             [URIs: unsubscribe.magnetmail.net]
  1.6 URIBL_SBL              Contains an URL's NS IP listed in the SBL blocklist
                             [URIs: unsubscribe.magnetmail.net]
 -0.0 RCVD_IN_MSPIKE_H2      RBL: Average reputation (+2)
                             [209.85.220.72 listed in wl.mailspike.net]
  0.0 HEADER_FROM_DIFFERENT_DOMAINS From and EnvelopeFrom 2nd level mail
                             domains are different
  0.0 T_KAM_HTML_FONT_INVALID BODY: Test for Invalidly Named or Formatted
                             Colors in HTML
 -1.9 BAYES_00               BODY: Bayes spam probability is 0 to 1%
                             [score: 0.0000]
  0.0 HTML_MESSAGE           BODY: HTML included in message
X-Spam-Flag: NO

--_NextPart_000_10960188_201593_114453747
Content-Type: text/plain; charset=UTF-8
Content-Transfer-Encoding: quoted-printable

To see the web version of this message click here:=20
http://contentsharing.net/actions/email_web_version.cfm?recipient_id=3D2295=
734738&message_id=3D10960188&user_id=3DVERTMARKET&jobid=3D29602822

Hello Noor -

In 2014, FDA provided guidance on the proper use of social media for makers=
 of prescription products. As the new year unfolds, many questions remain a=
bout how to properly implement these guidelines.

If you and your colleagues are looking to plan your 2015 social media strat=
egy in a way that mitigates compliance and brand risk, then join us for thi=
s 90-minute webinar:
FDA Guidance on Social Media: Questions Answered and Unanswered

REGISTER NOW
http://www.lifesciencetraininginstitute.com/doc/fda-guidance-on-social-medi=
a-questions-answered-and-unanswered-0001?utm_source=3DBlast&utm_medium=3DEm=
ail&utm_campaign=3DLSTI01

Date: Tuesday, October 13, 2015
Time: 1pm EDT US
Duration: 90 Minutes
Location: Live, interactive training on your computer
Price: $299 - Includes slides, handouts, exam, and completion certificate!

Course Description:

This session will provide an overview of the state of FDA guidance on socia=
l media with an emphasis on explaining where FDA has provided guidance on c=
ompliant use of social media and where FDA has failed to provide guidance. =
Additionally, this session will discuss how you can implement and manage pr=
ograms to mitigate compliance and brand risk.

Join our interactive online training course where you will learn:

- The current state of FDA guidance on social media
- Timing and next steps from FDA
- Settled areas of FDA guidance that are unlikely to change
- Controversial FDA positions that are likely to be revised
- Key issues of remaining uncertainty
- Risks vs. Benefits: "Selling" management on the importance of social medi=
a
- Managing your social media activities to protect your brand
- What's worked, what hasn't, and what's happened as a result

REGISTER NOW
http://www.lifesciencetraininginstitute.com/doc/fda-guidance-on-social-medi=
a-questions-answered-and-unanswered-0001?utm_source=3DBlast&utm_medium=3DEm=
ail&utm_campaign=3DLSTI01

Your Expert Instructor:

Dale Cooke is an industry expert on FDA enforcement trends, best practices =
for review processes, and life sciences use of social media.

Read More
http://www.lifesciencetraininginstitute.com/doc/fda-guidance-on-social-medi=
a-questions-answered-and-unanswered-0001?utm_source=3DBlast&utm_medium=3DEm=
ail&utm_campaign=3DLSTI01

We hope you can join us for this important event!

The LSTI Team

Life Science Training Institute (LSTI)
101 Gibraltar Rd., Ste. 100
Horsham, PA 19044
info@lifesciencetraininginstitute.com=20

*Use this link to unsubscribe:
http://www.magnetmail.net/Actions/unsubscribe.cfm?message_id=3D10960188&use=
r_id=3DVERTMARKET&recipient_id=3D2295734738&email=3Dsales_marketing@ferozso=
ns-labs.com&group_id=3D2258865

To unsubscribe from this group and stop receiving emails from it, send an e=
mail to sales_marketing+unsubscribe@ferozsons-labs.com.

--_NextPart_000_10960188_201593_114453747
Content-Type: text/html; charset=UTF-8
Content-Transfer-Encoding: quoted-printable

<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.=
w3.org/TR/html4/loose.dtd"><html xmlns=3D"http://www.w3.org/1999/xhtml"><he=
ad>=20
  <meta content=3D"text/html; charset=3Dutf-8" http-equiv=3D"Content-Type">=
=20
  <title>Life Science Training</title>=20
  <base target=3D"_blank">=20
 </head>=20
 <body style=3D"font-family: Calibri; font-size: 11pt">
  <div style=3D"display:none !important; visibility: hidden !important; opa=
city: 0 !important; color: transparent !important; height: 0px !important; =
width: 0px !important; font-size:0px; line-height:0; overflow:hidden; mso-h=
ide: all;" width=3D"0" height=3D"0">
   Encore Presentation! FDA Guidance on Social Media: Questions Answered an=
d Unanswered
  </div>=20
  <p>Hello Noor &ndash; </p>=20
  <p>In 2014, FDA provided guidance on the proper use of social media for m=
akers of prescription products. As the new year unfolds, many questions rem=
ain about how to properly implement these guidelines. </p>=20
  <p>If you and your colleagues are looking to plan your 2015 social media =
strategy in a way that mitigates compliance and brand risk, then join us fo=
r this 90-minute webinar: </p>=20
  <h3 style=3D"font-family: Calibri; font-style: italic"> <a href=3D"http:/=
/www.mmsend24.com/link.cfm?r=3D2295734738&amp;sid=3D81030490&amp;m=3D109601=
88&amp;u=3DVERTMARKET&amp;j=3D29602822&amp;s=3Dhttp://www.lifesciencetraini=
nginstitute.com/doc/fda-guidance-on-social-media-questions-answered-and-una=
nswered-0001?utm_source=3DBlast&amp;utm_medium=3DEmail&amp;utm_campaign=3DL=
STI01">FDA Guidance on Social Media: Questions Answered and Unanswered </a>=
</h3>=20
  <p> <a href=3D"http://www.mmsend24.com/link.cfm?r=3D2295734738&amp;sid=3D=
81030491&amp;m=3D10960188&amp;u=3DVERTMARKET&amp;j=3D29602822&amp;s=3Dhttp:=
//www.lifesciencetraininginstitute.com/doc/fda-guidance-on-social-media-que=
stions-answered-and-unanswered-0001?utm_source=3DBlast&amp;utm_medium=3DEma=
il&amp;utm_campaign=3DLSTI01">REGISTER NOW </a></p>=20
  <p>Date: Tuesday, October 13, 2015 <br> Time: 1pm EDT US <br> Duration: 9=
0 Minutes <br> Location: Live, interactive training on your computer <br> P=
rice: $299 &ndash; Includes slides, handouts, exam, and completion certific=
ate! </p>=20
  <p><strong>Course Description:</strong> </p>=20
  <p>This session will provide an overview of the state of FDA guidance on =
social media with an emphasis on explaining where FDA has provided guidance=
 on compliant use of social media and where FDA has failed to provide guida=
nce. Additionally, this session will discuss how you can implement and mana=
ge programs to mitigate compliance and brand risk. </p>=20
  <p>Join our interactive online training course where you will learn: </p>=
=20
  <ul type=3D"disc">=20
   <li>The current state of FDA guidance on social media </li>=20
   <li>Timing and next steps from FDA </li>=20
   <li>Settled areas of FDA guidance that are unlikely to change </li>=20
   <li>Controversial FDA positions that are likely to be revised </li>=20
   <li>Key issues of remaining uncertainty </li>=20
   <li>Risks vs. Benefits: "Selling" management on the importance of social=
 media </li>=20
   <li>Managing your social media activities to protect your brand </li>=20
   <li>What's worked, what hasn't, and what's happened as a result </li>=20
  </ul>=20
  <p> <a href=3D"http://www.mmsend24.com/link.cfm?r=3D2295734738&amp;sid=3D=
81030491&amp;m=3D10960188&amp;u=3DVERTMARKET&amp;j=3D29602822&amp;s=3Dhttp:=
//www.lifesciencetraininginstitute.com/doc/fda-guidance-on-social-media-que=
stions-answered-and-unanswered-0001?utm_source=3DBlast&amp;utm_medium=3DEma=
il&amp;utm_campaign=3DLSTI01">REGISTER NOW </a></p>=20
  <p><strong>Your Expert Instructor:</strong> </p>=20
  <p><strong>Dale Cooke</strong> is an industry expert on FDA enforcement t=
rends, best practices for review processes, and life sciences use of social=
 media... <a href=3D"http://www.mmsend24.com/link.cfm?r=3D2295734738&amp;si=
d=3D81030492&amp;m=3D10960188&amp;u=3DVERTMARKET&amp;j=3D29602822&amp;s=3Dh=
ttp://www.lifesciencetraininginstitute.com/doc/fda-guidance-on-social-media=
-questions-answered-and-unanswered-0001?utm_source=3DBlast&amp;utm_medium=
=3DEmail&amp;utm_campaign=3DLSTI01">Read More </a></p>=20
  <p>We hope you can join us for this important event! </p>=20
  <p>The LSTI Team </p>=20
  <p>Life Science Training Institute (LSTI) <br> 101 Gibraltar Rd., Ste. 10=
0 <br> Horsham, PA 19044 <br> <a href=3D"mailto:info@lifesciencetrainingins=
titute.com">info@lifesciencetraininginstitute.com</a> </p>  =20
  <p align=3D"center"> Click <a href=3D"http://www.mmsend24.com/link.cfm?r=
=3D2295734738&amp;sid=3D81030493&amp;m=3D10960188&amp;u=3DVERTMARKET&amp;j=
=3D29602822&amp;s=3Dhttp://unsubscribe.magnetmail.net/Actions/unsubscribe.c=
fm?message_id=3D10960188&amp;user_id=3DVERTMARKET&amp;recipient_id=3D229573=
4738&amp;email=3Dsales_marketing@ferozsons-labs.com&amp;group_id=3D2258865"=
>here</a> to unsubscribe.</p>
=20
<br><img src=3D"http://www.mmsend24.com/spacer.cfm?tracking_id=3D2739099655=
2&amp;jid=3D29602822"></body></html>

<p></p>

To unsubscribe from this group and stop receiving emails from it, send an e=
mail to <a href=3D"mailto:sales_marketing+unsubscribe@ferozsons-labs.com">s=
ales_marketing+unsubscribe@ferozsons-labs.com</a>.<br />

--_NextPart_000_10960188_201593_114453747--
